AXL and neoplasm: Inhibition of AXL reversed chemoresistance by decreasing expression of the anti-apoptotic proteins BCL-2, BCL-XL, MCL1 and survivin in tumor cells and activated pro-apoptotic proteins BAD, BAX, BCL-2, BAK and PUMA.